Suba Krishnan

Suba Krishnan is an accomplished biopharmaceutical executive with extensive experience in clinical development, particularly in immuno-oncology. Currently serving as Senior Vice President of Clinical Development at Mereo BioPharma since December 2020, Suba has held leadership positions at Genmab as Vice President and Global Program Head for Immunooncology, and at Merck as Senior Principal Scientist overseeing the Lynparza Tumor Agnostic Strategy. Previous roles include Senior Director at MedImmune, Director of Global Clinical Research at Bristol-Myers Squibb, and Director of Experimental Medicine at Shire Pharmaceuticals. Suba's academic background includes significant research and teaching roles at leading institutions, including Thomas Jefferson University and Columbia University, following an MBBS degree from Armed Forces Medical College, Pune University.